Abstract:Abstract Background Cholesterol plays vital roles in human physiology; abnormal levels have deleterious pathological consequences. In cancer, elevated or reduced expression of cholesterol biosynthesis is associated with good or poor prognosis, but the underlying mechanisms are largely unknown. The limonoid compounds A1542 and A1543 stimulate ERK/MAPK by direct binding, leading to leukemic cell death and suppression of leukemia in mouse models. In this study, we investigated the downstream consequences of these ERK/MAPK agonists in leukemic cells. Methods We employed RNAseq analysis combined with Q-RT-PCR, western blot and bioinformatics to identify and confirm genes whose expression was altered by A1542 and A1543 in leukemic cells. ShRNA lentiviruses were used to silence gene expression. Cell culture and an animal model (BALB/c) of erythroleukemia induced by Friend virus were utilized to validate effects of cholesterol on leukemia progression. Results RNAseq analysis of A1542-treated cells revealed the induction of all 18 genes implicated in cholesterol biosynthesis. Expression of these cholesterol genes was blocked by cedrelone, an ERK inhibitor. The cholesterol inhibitor lovastatin diminished ERK/MAPK activation by A1542, thereby reducing leukemic cell death induced by this ERK1/2 agonist. Growth inhibition by cholesterol was observed both at the intracellular level, and when orally administrated into a leukemic mouse model. Both HDL and LDL also suppressed leukemogenesis, implicating these lipids as important prognostic markers for leukemia progression. Mechanistically, knockdown experiments revealed that the activation of SREBP1/2 by A1542-A1543 was responsible for induction of only a sub-set of cholesterol biosynthesis genes. Induction of other regulatory factors by A1542-A1543 including EGR1 , AP1 (FOS + JUN) LDLR, IER2 and others may cooperate with SREBP1/2 to induce cholesterol genes. Indeed, pharmacological inhibition of AP1 significantly inhibited cholesterol gene expression induced by A1542. In addition to leukemia, high expression of cholesterol biosynthesis genes was found to correlate with better prognosis in renal cancer. Conclusions This study demonstrates that ERK1/2 agonists suppress leukemia and possibly other types of cancer through transcriptional stimulation of cholesterol biosynthesis genes.

Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells

Ezrin dephosphorylation|[sol]|downregulation contributes to ursolic acid-mediated cell death in human leukemia cells

Acetylation of Ezrin Regulates Membrane-Cytoskeleton Interaction Underlying CCL18-elicited Cell Migration.

A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells

Ursolic Acid Induces Apoptosis in Human Leukaemia Cells and Exhibits Anti-Leukaemic Activity in Nude Mice Through the Pkb Pathway

RhoA Modulates Functional and Physical Interaction Between ROCK1 and Erk1/2 in Selenite-Induced Apoptosis of Leukaemia Cells

Dephosphorylation and mitochondrial translocation of cofilin sensitizes human leukemia cells to cerulenin-induced apoptosis via the ROCK1/Akt/JNK signaling pathway.

Ursolic Acid Enhances Apoptosis in K562 Cells

Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and suppression of ERK1/2 MAPK in HeLa cells.

The Ubiquitin-Activating Enzyme E1 As a Therapeutic Target for the Treatment of Leukemia and Multiple Myeloma.

Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.

EZH2 Mediates ATO-induced Apoptosis in Acute Myeloid Leukemia Cell Lines Through the Wnt Signaling Pathway

Inhibition Of Erk5 Enhances Cytarabine-Induced Apoptosis In Acute Myeloid Leukemia Cells

Ursolic acid induces apoptosis and pyroptosis in Reh cells by upregulating of the JNK signalling pathway based on network pharmacology and experimental validation

Crucial Role of Heme Oxygenase-1 in the Sensitivity of Acute Myeloid Leukemia Cell Line Kasumi-1 to Ursolic Acid

Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is Essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells

Autophagy-Dependent Eif2ak3 Activation Compromises Ursolic Acid-Induced Apoptosis Through Upregulation of Mcl1 in Mcf-7 Human Breast Cancer Cells

Ubiquitin-Activating Enzyme E1 Inhibition Caused Acute Leukemia Cell Apoptosis by Affecting CHOP Pathway

ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes

Downregulation of Survivin and Activation of Caspase-3 Through the Pi3k/Akt Pathway in Ursolic Acid-Induced Hepg2 Cell Apoptosis

Ursolic Acid Induces HL60 Monocytic Differentiation and Upregulates C/EBPβ Expression by ERK Pathway Activation